Multivariate analysis to predict risk of stenosis among subset of patients with GCA
| Covariate | HR | 95% CI | p Value |
|---|---|---|---|
| Age | |||
| >6 months | Reference | >6 months | Reference |
| ≤6 months | 2.62 | 1.04 to 6.63 | 0.04 |
| IVIG | |||
| 1 dose | Reference | ||
| 2 (+) doses | 1.28 | 0.38 to 4.27 | 0.69 |
GCA, giant coronary aneurysms; IVIG, intravenous immunoglobulin.